首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling
Institution:1. College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China;2. Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China;3. The First Affiliation Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, China;4. Huzhou Institute for Food and Drug Control, Huzhou 313000, China;5. College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China;6. Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA;1. Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, TR-34755, Kay??da??, ?stanbul, Turkey;2. Department of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Szeged 6720, Hungary;3. Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Szeged 6720, Hungary;4. Interdisciplinary Centre of Natural Products, University of Szeged, Szeged 6720, Hungary;1. School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China;2. The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China;3. The Second Affiliated Hospital and Yuying Children''s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China;4. The Institute of Life Sciences, Wenzhou University, Wenzhou, Zhejiang 325035, China;5. Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325600, China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号